90
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Neuroprotective effect of taxifolin against aluminum chloride-induced dementia and pathological alterations in the brain of rats: possible involvement of toll-like receptor 4

ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 703-716 | Received 04 May 2023, Accepted 07 Mar 2024, Published online: 25 Mar 2024

References

  • Blaylock RL. 2012. Aluminum induced immunoexcitotoxicity in neurodevelopmental and neurodegenerative disorders. Curr Inorg Chem. 2(1):46–53.
  • Booth AN, Deeds F. 1958. The toxicity and metabolism of dihydroquercetin. J Am Pharm Assoc Am Pharm Assoc. 47(3):183–184. doi: 10.1002/jps.3030470310.
  • Bradley PP, Priebat DA, Christensen RD, Rothstein G. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 78(3):206–209. doi: 10.1111/1523-1747.ep12506462.
  • Bromley-Brits K, Deng Y, Song W. 2011. Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice. J Vis Exp. 53(53):2920. doi: 10.3791/2920.
  • Bushinsky DA, Sprague SM, Hallegot P, Girod C, Chabala JM, Levi-Setti R. 1995. Effects of aluminum on bone surface ion composition. J Bone Miner Res. 10(12):1988–1997. doi: 10.1002/jbmr.5650101219.
  • Chavali VD, Agarwal M, Vyas VK, Saxena B. 2020. Neuroprotective effects of ethyl pyruvate against aluminum chloride-induced alzheimer’s disease in rats via inhibiting toll-like receptor 4. J Mol Neurosci. 70(6):836–850. doi: 10.1007/s12031-020-01489-9.
  • Chobot V, Hadacek F, Bachmann G, Weckwerth W, Kubicova L. 2016. Pro- and antioxidant activity of three selected flavan type flavonoids: catechin, eriodictyol and taxifolin. Int J Mol Sci. 17(12):1986. doi: 10.3390/ijms17121986.
  • Clark WM, Madden KP, Rothlein R, Zivin JA. 1991. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke. 22(7):877–883. doi: 10.1161/01.str.22.7.877.
  • Colomina MT, Roig JL, Sánchez DJ, Domingo JL. 2002. Influence of age on aluminum-induced neurobehavioral effects and morphological changes in rat brain. Neurotoxicology. 23(6):775–781. doi: 10.1016/S0161-813X(02)00008-6.
  • Dey M, Singh RK. 2022a. Chronic oral exposure of aluminum chloride in rat modulates molecular and functional neurotoxic markers relevant to Alzheimer’s disease. Toxicol Mech Methods. 32(8):616–627. doi: 10.1080/15376516.2022.2058898.
  • Dey M, Singh RK. 2022b. Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer’s disease. Pharmacol Rep. 74(3):439–450. doi: 10.1007/s43440-022-00353-4.
  • Ding Q, Chen K, Liu X, Ding C, Zhao Y, Sun S, Zhang Y, Zhang J, Liu S, Liu W. 2022. Modification of taxifolin particles with an enteric coating material promotes repair of acute liver injury in mice through modulation of inflammation and autophagy signaling pathway. Biomed Pharmacother. 152:113242. doi: 10.1016/j.biopha.2022.113242.
  • Dok-Go H, Lee KH, Kim HJ, Lee EH, Lee J, Song YS, Lee YH, Jin C, Lee YS, Cho J. 2003. Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten. Brain Res. 965(1–2):130–136. doi: 10.1016/s0006-8993(02)04150-1.
  • Draper HH, Hadley M. 1990. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 186:421–431. doi: 10.1016/0076-6879(90)86135-i.
  • Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82(1):70–77. doi: 10.1016/0003-9861(59)90090-6.
  • Exley C. 2001. Aluminum and Alzheimer’s disease. J Alzheimers Dis. 3(6):551–552. doi: 10.3233/jad-2001-3605.
  • Exley C. 2005. The aluminium-amyloid cascade hypothesis and Alzheimer’s disease. Subcell Biochem. 38:225–234.
  • Forghani R, Kim HJ, Wojtkiewicz GR, Bure L, Wu Y, Hayase M, Wei Y, Zheng Y, Moskowitz MA, Chen JW. 2015. Myeloperoxidase propagates damage and is a potential therapeutic target for subacute stroke. J Cereb Blood Flow Metab. 35(3):485–493. doi: 10.1038/jcbfm.2014.222.
  • Galijasevic S, Saed GM, Diamond MP, Abu-Soud HM. 2003. Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. Proc Natl Acad Sci USA. 100(25):14766–14771. doi: 10.1073/pnas.2435008100.
  • Ghosh A, Dhumal VR, Tilak AV, Das N, Singh A, Bondekar AA. 2011. Evaluation of nootropic and neuroprotective effects of low dose aspirin in rats. J Pharmacol Pharmacother. 2(1):3–6. doi: 10.4103/0976-500X.77079.
  • Gupta MB, Bhalla NT, Gupta GP, Bhargava KP, Mitra CR. 1971. Anti-inflammatory activity of taxifolin. Jpn J Pharmacol. 21(3):377–382. doi: 10.1254/jjp.21.377.
  • Hanisch UK, Johnson TV, Kipnis J. 2008. Toll-like receptors: roles in neuroprotection? Trends Neurosci. 31(4):176–182. doi: 10.1016/j.tins.2008.01.005.
  • Hanke ML, Kielian T. 2011. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond). 121(9):367–387. doi: 10.1042/CS20110164.
  • Hevel JM, Marletta MA. 1994. Nitric-oxide synthase assays. Methods in enzymology. Vol. 233. Amsterdam, Netherlands: Elsevier; 250–258.
  • Inoue T, Saito S, Tanaka M, Yamakage H, Kusakabe T, Shimatsu A, Ihara M, Satoh-Asahara N. 2019. Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy. Proc Natl Acad Sci USA. 116(20):10031–10038. doi: 10.1073/pnas.1901659116.
  • Kabel AM, Arab HH, Abd Elmaaboud MA. 2021. Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: the interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis. Hum Exp Toxicol. 40(10):1710–1720. doi: 10.1177/09603271211008496.
  • Kaur A, Joshi K, Minz RW, Gill KD. 2006. Neurofilament phosphorylation and disruption: a possible mechanism of chronic aluminium toxicity in Wistar rats. Toxicology. 219(1–3):1–10. doi: 10.1016/j.tox.2005.09.015.
  • Kawahara M, Kato M, Kuroda Y. 2001. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res Bull. 55(2):211–217. doi: 10.1016/s0361-9230(01)00475-0.
  • Kielian T. 2006. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res. 83(5):711–730. doi: 10.1002/jnr.20767.
  • Kolhir VK, Bykov VA, Baginskaja AI, Sokolov SY, Glazova NG, Leskova TE, Sakovich GS, Tjukavkina NA, Kolesnik YA, Rulenko IA. 1996. Antioxidant activity of a dihydroquercetin isolated from Larix gmelinii (Rupr.) Rupr Wood Phytother Res. 10(6):478–482. doi: 10.1002/(SICI)1099-1573(199609)10:6<478::AID-PTR883>3.0.CO;2-S.
  • Kraeuter AK, Guest PC, Sarnyai Z. 2019. The Y-maze for assessment of spatial working and reference memory in mice. Methods Mol Biol. 1916:105–111. doi: 10.1007/978-1-4939-8994-2_10.
  • Kumar V, Gill KD. 2014. Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review. Neurotoxicology. 41:154–166. doi: 10.1016/j.neuro.2014.02.004.
  • Lad KA, Maheshwari A, Saxena B. 2019. Repositioning of an anti-depressant drug, agomelatine as therapy for brain injury induced by craniotomy. Drug Discov Ther. 13(4):189–197. doi: 10.5582/ddt.2019.01056.
  • Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA. 100(14):8514–8519. doi: 10.1073/pnas.1432609100.
  • Malle E, Marsche G, Arnhold J, Davies MJ. 2006. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta. 1761(4):392–415. doi: 10.1016/j.bbalip.2006.03.024.
  • Martínez-Hernández MI, Acosta-Saavedra LC, Hernández-Kelly LC, Loaeza-Loaeza J, Ortega A. 2023. Microglial activation in metal neurotoxicity: impact in neurodegenerative diseases. Biomed Res Int. 2023:7389508–7389527. doi: 10.1155/2023/7389508.
  • Miu AC, Andreescu CE, Vasiu R, Olteanu AI. 2003. A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum. Int J Neurosci. 113(9):1197–1211. doi: 10.1080/00207450390232292.
  • Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 19(14):1639–1662. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.
  • Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. 2009. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 30(16):2785–2791. doi: 10.1002/jcc.21256.
  • Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 11(1):47–60. doi: 10.1016/0165-0270(84)90007-4.
  • Ochmański W, Barabasz W. 2000. Aluminum – occurrence and toxicity for organisms. Przegl Lek. 57(11):665–668. https://pubmed.ncbi.nlm.nih.gov/11293216/.
  • Ohto U, Fukase K, Miyake K, Satow Y. 2007. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science. 316(5831):1632–1634. doi: 10.1126/science.1139111.
  • Praticò D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VMY. 2002. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 16(9):1138–1140. doi: 10.1096/fj.02-0012fje.
  • Rui D, Yongjian Y. 2010. Aluminum chloride induced oxidative damage on cells derived from hippocampus and cortex of ICR mice. Brain Res. 1324:96–102. doi: 10.1016/j.brainres.2010.02.024.
  • Sahin G, Varol I, Temizer A, Benli K, Demirdamar R, Duru S. 1994. Determination of aluminum levels in the kidney, liver, and brain of mice treated with aluminum hydroxide. Biol Trace Elem Res. 41(1–2):129–135. doi: 10.1007/BF02917223.
  • Saxena B, Chavali VD. 2019. The role of toll like receptor 4 in pathogenesis of Alzheimer’s disease induced by aluminum chloride. Int J Emerg Technol Innov Res. 6(4):96–99.
  • Schauss AG, Tselyico SS, Kuznetsova VA, Yegorova I. 2015. Toxicological and genotoxicity assessment of a dihydroquercetin-rich dahurian larch tree (Larix gmelinii Rupr) extract (Lavitol). Int J Toxicol. 34(2):162–181. doi: 10.1177/1091581815576975.
  • Takeda K, Akira S. 2004. TLR signaling pathways. Semin Immunol. 16(1):3–9. doi: 10.1016/j.smim.2003.10.003.
  • Wakayama I, Song KJ, Nerurkar VR, Yoshida S, Garruto RM. 1997. Slow dendritic transport of dissociated mouse hippocampal neurons exposed to aluminum. Brain Res. 748(1–2):237–240. doi: 10.1016/s0006-8993(96)01314-5.
  • Walker VR, Sutton RA, Meirav O, Sossi V, Johnson R, Klein J, Fink D, Middleton R. 1994. Tissue disposition of 26aluminum in rats measured by accelerator mass spectrometry. Clin Invest Med. 17(5):420–425.
  • Walton JR. 2012. Aluminum disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer’s disease. J Alzheimers Dis. 29(2):255–273. doi: 10.3233/JAD-2011-111712.
  • Wang YH, Wang WY, Chang CC, Liou KT, Sung YJ, Liao JF, Chen CF, Chang S, Hou YC, Chou YC, et al. 2006. Taxifolin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-oxidative effect and modulation of NF-kappa B activation. J Biomed Sci. 13(1):127–141. doi: 10.1007/s11373-005-9031-0.
  • Wills MR, Hewitt CD, Savory J, Herman MM. 1993. Long-term oral aluminum administration in rabbits. II. Brain and other organs. Ann Clin Lab Sci. 23(1):17–23.
  • Wills MR, Hewitt CD, Sturgill BC, Savory J, Herman MM. 1993. Long-term oral or intravenous aluminum administration in rabbits. I. Renal and hepatic changes. Ann Clin Lab Sci. 23(1):1–16.
  • Xie X, Feng J, Kang Z, Zhang S, Zhang L, Zhang Y, Li X, Tang Y. 2017. Taxifolin protects RPE cells against oxidative stress-induced apoptosis. Mol Vis. 23:520–528.
  • Yang X, Cao Z, Zhang J, Shao B, Song M, Han Y, Li Y. 2018. Dendritic spine loss caused by AlCl3 is associated with inhibition of the Rac 1/cofilin signaling pathway. Environ Pollut. 243(Pt B):1689–1695. doi: 10.1016/j.envpol.2018.09.145.
  • Yokel RA. 2000. The toxicology of aluminum in the brain: a review. Neurotoxicology. 21(5):813–828.
  • Yokel RA. 2002. Brain uptake, retention, and efflux of aluminum and manganese. Environ Health Perspect. 110(5):699–704. doi: 10.1289/ehp.02110s5699.
  • Yokel RA, McNamara PJ. 2001. Aluminium toxicokinetics: an updated minireview. Pharmacol Toxicol. 88(4):159–167. doi: 10.1034/j.1600-0773.2001.d01-98.x.
  • Zhang C, Zhan J, Zhao M, Dai H, Deng Y, Zhou W, Zhao L. 2019. Protective mechanism of Taxifolin for chlorpyrifos neurotoxicity in BV2 cells. NeuroToxicology. 74:74–80. doi: 10.1016/j.neuro.2019.05.010.
  • Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda CE, Hazen SL. 2002. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem. 277(48):46116–46122. doi: 10.1074/jbc.M209124200.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.